Ameriprise Financial Inc Apellis Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 860,294 shares of APLS stock, worth $28.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

860,294

Previous 783,914 9.74%

Holding current value

$28.5 Million

Previous $30.1 Million 17.49%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $2.2 Million - $3.14 Million	76,380 Added 9.74%	860,294 $24.8 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $9.61 Million - $15.1 Million	252,552 Added 47.53%	783,914 $30.1 Million
Q1 2024 May 15, 2024	SELL	$55.39 - $72.47 $1.9 Million - $2.48 Million	-34,218 Reduced 6.05%	531,362 $31.2 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $7.92 Million - $13.8 Million	213,188 Added 60.5%	565,580 $33.9 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $5 Million - $18.9 Million	211,314 Added 149.79%	352,392 $13.4 Million
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $4.71 Million - $5.73 Million	61,405 Added 77.07%	141,078 $12.9 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $1.03 Million - $1.48 Million	22,033 Added 38.23%	79,673 $5.26 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $47,520 - $67,082	1,099 Added 1.94%	57,640 $2.98 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $5.47 Million - $8.51 Million	-122,163 Reduced 68.36%	56,541 $3.86 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $318,540 - $537,804	9,083 Added 5.35%	178,704 $8.08 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $104,004 - $158,733	2,933 Added 1.76%	169,621 $8.62 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $1.11 Million - $1.77 Million	-36,024 Reduced 17.77%	166,688 $7.88 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $2.15 Million - $4.79 Million	68,555 Added 51.1%	202,712 $6.68 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $5.49 Million - $8.71 Million	134,157 New	134,157 $8.48 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $343,872 - $851,136	-19,200 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$22.1 - $30.8 $28,730 - $40,040	-1,300 Reduced 6.34%	19,200 $589,000
Q3 2019 Nov 14, 2019	SELL	$24.09 - $32.18 $1.63 Million - $2.18 Million	-67,670 Reduced 76.75%	20,500 $494,000
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $722,016 - $1.02 Million	40,112 Added 83.47%	88,170 $2.23 Million
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $615,622 - $952,509	48,058 New	48,058 $937,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Apellis Pharmaceuticals, Inc. Transaction History